Sbi Securities Co., Ltd. Ascendis Pharma A/S Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 3 shares of ASND stock, worth $587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 3
-0.0%
Holding current value
$587
Previous $468,000
10.68%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ASND
# of Institutions
280Shares Held
61.6MCall Options Held
202KPut Options Held
201K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.01 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.07 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$1.02 Billion13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$878 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$833 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $10.9B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...